Institute For Clinical Evaluative Sciences

Rediff.com » News » Institute For Clinical Evaluative Sciences

News for Institute For Clinical Evaluative Sciences

News
Business

Covaxin emergency use decision likely in 4-6 weeks: WHO

The World Health Organization is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the......

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

The recruitment for the clinical trial of the country's first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS in New Delhi......

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. IMAGE: Kindly......

India's COVID-19 figures worrying: WHO chief scientist

As India is in the grasp of a devastating second wave of COVID-19, World Health Organisation chief scientist Soumya Swaminathan on Monday termed the rate of infections and deaths in the country as......

Speedy distribution of vaccine major global challenge: WHO experts

As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines......

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

This year's Laureates have shown how the problem of global poverty can be tackled by breaking it down into a number of smaller - but more precise - questions at individual or group levels, he Royal......

What's common between Baba Ramdev and Tatas?

Baba Ramdev and the Tata Group are poles apart in their area of operations, but they have one thing in common: both have been quick to spot the money-spinning potential of Ayurveda's healing touch.......

Ayurveda's healing touch draws big business

Pharma majors open new R&D chapter

USV, a Mumbai-based Rs 800 crore drug manufacturer with research expertise in small molecules and proteins, recently decided to venture into the lucrative segment of vaccines. For that, it decided......

Chidambaram's Budget speech

Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......

Rediff News

Institute For Clinical Evaluative Sciences

News for Institute For Clinical Evaluative Sciences

Covaxin emergency use decision likely in 4-6 weeks: WHO

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

India's COVID-19 figures worrying: WHO chief scientist

Speedy distribution of vaccine major global challenge: WHO experts

Innovative field research in India helped Abhijit Banerjee and Esther Duflo win Economics Nobel

What's common between Baba Ramdev and Tatas?

Ayurveda's healing touch draws big business

Pharma majors open new R&D chapter

Chidambaram's Budget speech

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS